Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities
Open Access
- 1 May 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 16 (5) , 861-871
Abstract
Tacrolimus (TAC) and mycophenolic acid (MPA) provide maintenance immunosuppression and is dosed empirically in elderly kidney transplant recipients (KTRs) resulting in health inequities. Limited immunosuppressive pharmacokinetics are available comparing adult ages. This secondary analysis compared TAC and MPA pharmacokinetics and adverse effects (AEs) among young, middle-aged, and elderly Black and White KTRs. The 12-h TAC and MPA pharmacokinetics with AE evaluation were conducted in 67 stable KTRs greater than or equal to 6 months post-transplant. TAC regimens were adjusted to target troughs. MPA regimens were adjusted using clinical response. Participants were: young: less than or equal to 40 years; middle age: greater than 40 to 60 years, and elderly greater than 60 years. Noncompartmental pharmacokinetic analysis determined area under the concentration-time curve 0-12h (AUC(0-12h)), clearance (CL), and CL/body mass index (BMI) with 0-h troughs. MPA enterohepatic recirculation (EHR), MPA-AUC(6-12h)/MPA-AUC(0-12h), and MPA glucuronide (MPAG)-AUC(0-12h)/ MPA-AUC(0-12h) were determined. Univariate analysis of variance (ANOVA) was conducted using SAS version 9.4. No group differences were noted for estimated glomerular filtration rate, MPA, and TAC doses. EHR was reduced in elderly with decreased MPA-AUC(6-12h)/MPA-AUC(0-12h) (p = 0.049) and increased MPAG-AUC(0-12h/)MPA-AUC(0-12h) (p = 0.036). MPA troughs (p = 0.045) were reduced in the elderly. TAC CL/BMI (p = 0.043) was reduced in the elderly. For therapeutic MPA AUC(0-12h): 30-60 mg center dot h/L, 34.3% KTRs achieved this target with 55.2% greater than the therapeutic range. 77.6% KTR were in the TAC AUC(0-12h) target: 100-190 ng center dot h/mL and 19.4% were below this range with no age relationship. In 44% young, 26% middle-age and 7.8% elderly subjects achieved target AUC(0-12)h for both medications (p = 0.036). Neurologic AEs were manifested in the elderly (p = 0.014). Immunosuppressive pharmacokinetics demonstrated age-related differences with reduced TAC CL/BMI and MPA EHR and increased neurologic AE in the elderly. This immunosuppressive regimen may require age-adjusted individualization to optimize allograft function. Study Highlights WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Tacrolimus (TAC) and mycophenolic acid (MPA) provide maintenance immunosuppression and are dosed empirically in elderly kidney transplant recipients (KTRs) resulting in health inequities. Limited immunosuppressive pharmacokinetics are available comparing adult ages. This secondary analysis compared TAC and MPA pharmacokinetics and adverse effects (AEs) among young, middle-aged, and elderly Black and White KTRs. WHAT QUESTION DID THIS STUDY ADDRESS? This secondary analysis compared TAC and MPA pharmacokinetics and AEs among young, middle--aged, and elderly Black and White KTRs. WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE? This secondary analysis reported age--related differences in the commonly prescribed TAC and MPA regimen in stable KTRs. Reduced TAC Clearance/BMI and MPA enterohepatic recirculation and increased neurologic AEs were reported in the elderly. HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY AND TRANSLATIONAL SCIENCE? This report suggests that TAC and MPA immunosuppressive regimen may require age--adjusted individualization to achieve therapeutic exposure and the benefits of this approach must be confirmed in a larger KTR population.Keywords
This publication has 31 references indexed in Scilit:
- Pharmacology and toxicology of mycophenolate in organ transplant recipients: an updateArchives of Toxicology, 2014
- Solid-Organ Transplantation in Older Adults: Current Status and Future ResearchAmerican Journal of Transplantation, 2012
- Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar TroughsAmerican Journal of Transplantation, 2012
- The Impact of Medicare’s Lifetime Immunosuppression Coverage on Racial Disparities in Kidney Graft SurvivalAmerican Journal of Transplantation, 2012
- Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meetingTransplantation Reviews, 2011
- Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2007
- Understanding the Influence of Ethnicity on Renal Allograft SurvivalAmerican Journal of Transplantation, 2005
- Health Disparities in Transplantation: Focus on the Complexity and Challenge of Renal Transplantation in African AmericansMedical Clinics of North America, 2005
- Age-related changes in liver structure and function: Implications for disease ?Experimental Gerontology, 2005
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999